VACLAVIK, J., M. KRISTKOVA, T. OPRSALOVA, Jiří JARKOVSKÝ, Klára BENEŠOVÁ, E. KOCIANOVA, M. KAMASOVA and L. JELINEK. IS CONFIRMATORY TESTING NEEDED IN ALL PATIENTS WITH POSITIVE SCREENING TEST FOR PRIMARY ALDOSTERONISM? In 29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH). 2019. ISSN 0263-6352. Available from: https://dx.doi.org/10.1097/01.hjh.0000570672.73711.19.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name IS CONFIRMATORY TESTING NEEDED IN ALL PATIENTS WITH POSITIVE SCREENING TEST FOR PRIMARY ALDOSTERONISM?
Authors VACLAVIK, J., M. KRISTKOVA, T. OPRSALOVA, Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Klára BENEŠOVÁ (203 Czech Republic, belonging to the institution), E. KOCIANOVA, M. KAMASOVA and L. JELINEK.
Edition 29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH), 2019.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.171
RIV identification code RIV/00216224:14310/19:00113709
Organization unit Faculty of Science
ISSN 0263-6352
Doi http://dx.doi.org/10.1097/01.hjh.0000570672.73711.19
UT WoS 000481429700080
Keywords in English primary hyperaldosteronism
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 21/4/2020 15:52.
Abstract
Primary hyperaldosteronism (PHA) is one of the most common causes of secondary hypertension. The aim of this work was to evaluate whether confirmatory testing is necessary in all patients with a positive screening test.
PrintDisplayed: 18/7/2024 00:35